Literature DB >> 19590973

The clearance of unidentified uremic solutes (with molecular weight under 5 kDa) plays an important role in hemodialyzer selection.

Tung-Sheng Chen1, Shaw-Yih Liou, Yen-Lin Chang.   

Abstract

BACKGROUND: The purpose of this study was to evaluate two commercial hemodialyzers (F100 and P21) through the clearance of identified and unidentified uremic solutes.
METHODS: We investigated plasma samples from healthy and uremic subjects.
RESULTS: We found three unidentified uremic solutes (P1, P2, and P3) after HPLC analysis of plasma samples. Then, we determined the clearance of four identified and the three unidentified uremic solutes in patients with F100 and P21. There was no significance between F100 and P21 in clearance of four identified uremic solutes. By contrast, the clearance of P1 and P2 with F100 was superior with the P21 (P < 0.05).
CONCLUSION: Our data suggest that selection of a hemodialyzer based on the clearance of identified uremic solutes might not be sufficient. Application of external techniques to determine additional external factors (i.e., clearance of unidentified uremic solutes) can facilitate a better decision in the selection of the ideal hemodialyzer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590973     DOI: 10.1007/s11255-009-9613-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  Uraemic toxins and cardiovascular disease.

Authors:  Raymond Vanholder; Griet Glorieux; Norbert Lameire
Journal:  Nephrol Dial Transplant       Date:  2003-03       Impact factor: 5.992

2.  In vitro and in vivo evaluation of a new dialyzer.

Authors:  Michael Külz; Bernd Nederlof; Hans Schneider
Journal:  Nephrol Dial Transplant       Date:  2002-08       Impact factor: 5.992

Review 3.  New insights in uremic toxins.

Authors:  Raymond Vanholder; Griet Glorieux; Rita De Smet; Norbert Lameire
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

4.  Dialytic performance evaluation of Rexeed: a new polysulfone-based dialyzer with improved flow distributions.

Authors:  A Brendolan; F Nalesso; A Fortunato; C Crepaldi; M De Cal; S Cazzavillan; D Cruz; N Techawathanawanna; C Ronco
Journal:  Int J Artif Organs       Date:  2005-10       Impact factor: 1.595

5.  Barriers to the delivery of adequate hemodialysis in ESRD Network 4.

Authors:  P M Palevsky; M S Washington; J A Stevenson; J M Rohay; N J Dyer; R Lockett; S B Perry
Journal:  Adv Ren Replace Ther       Date:  2000-10

Review 6.  Survival of hemodialysis patients and uremic toxin removal.

Authors:  R Vanholder; R De Smet; G Glorieux; A Dhondt
Journal:  Artif Organs       Date:  2003-03       Impact factor: 3.094

7.  Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.

Authors:  Jay P Garg; Scott Chasan-Taber; Andrew Blair; Melissa Plone; Juergen Bommer; Paolo Raggi; Glenn M Chertow
Journal:  Arthritis Rheum       Date:  2005-01

8.  A new method to evaluate the local clearance at different annular rings inside hemodialyzers.

Authors:  Zhongping Huang; Elias Klein; Baochun Li; Churn Poh; Zhijie Liao; William R Clark; Dayong Gao
Journal:  ASAIO J       Date:  2003 Nov-Dec       Impact factor: 2.872

9.  Relationship of dose of hemodialysis and cause-specific mortality.

Authors:  W E Bloembergen; D C Stannard; F K Port; R A Wolfe; J A Pugh; C A Jones; J W Greer; T A Golper; P J Held
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

10.  A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy.

Authors:  Frank A Gotch; Froilan Panlilio; Olga Sergeyeva; Laura Rosales; Tom Folden; George Kaysen; Nathan W Levin
Journal:  Blood Purif       Date:  2003       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.